Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Colin Geary Visiting Professor

Professor Adrian HarrisAdrian Harris

Cancer Research UK Professor of Medical Oncology, University of Oxford

Public Lecture: Breast cancer and new aspects of glutamine metabolism: metformin, exosomes, hormone resistance and repurposed drugs

Monday 4 March 6.00pm
Dunedin Public Art Gallery
Complimentary refreshments from 5:00pm

Free of charge. All welcome.

Pathology Seminar: How we are going to cure cancer

Tuesday 5 March 1.00pm
Colquhoun Lecture Theatre, Dunedin Hospital
Free of charge. All welcome.

Professor Adrian Harris MB.ChB, BSc Hons, MA, DPhil, MD (Hon), FRCP, FMedSci, DSc(Med) has been the Cancer Research UK Professor of Medical Oncology at the University of Oxford since 1989 and directs the Cancer Research UK Molecular Oncology Laboratories at the Weatherall Institute of Molecular Medicine (WIMM). He is a Consultant Medical Oncologist and a Professorial Fellow of St Hugh’s College Oxford. He is Editor-in-Chief of the British Journal of Cancer and on the Editorial Board of Cancer Cell. He is a Senior Investigator in the National Institute of Health Research and a Fellow of the Academy of Medical Sciences.

He is a ‘Highly Cited Researcher 2014’ ranking among the top 1% most cited for their subject field and year of publication—between 2002 and 2012 and included in Thompson Reuters ‘2014 World’s most Influential Scientific Minds.’ This has been maintained over last 5 years. He has published over 500 articles and there are over 140,000 citations to them, Google Scholar h index 183.

His major laboratory interests involve the role of hypoxia in breast tumour biology, and tumour angiogenesis, the metabolic response to hypoxia, noncoding RNAs induced by hypoxia and hypoxia-induced cell death, and interferon signalling. He has conducted many predictive and prognostic studies in breast cancer, and early exploratory phase trials in new drug development, molecular pathology and biomarkers to develop new agents with pharmacodynamic monitoring for proof of target engagement.

For any enquiries about the public lecture or seminar, please contact Alison Tait on or 03 479 7142